Foto de stock - 04 March 2021, Baden-Wuerttemberg, Heidelberg: An employee holds a so-called flowcell above a DNA sequencer in a sequencing laboratory at the European Molecular Biology Laboratory (EMBL). In the laboratory, positive SARS-CoV-2 samples are systematically examined for mutations. The aim is to rapidly identify mutations that pose a particular risk in terms of transmissibility, disease severity and vaccine efficacy. Photo: Uwe Anspach/dpa. - Heidelberg/Baden-Wuerttemberg/Germany

Imagen: 04 March 2021, Baden-Wuerttemberg, Heidelberg: An employee holds a so-called flowcell above a DNA sequencer in a sequencing laboratory at the European Molecular.

Criterios de búsqueda

  • Salud
  • Positivo
  • Medicina
  • Vacuna
  • Apuntando
  • Alemania
  • Enfermedad
  • Riesgo
  • Ciencia
  • Investigación
  • Sujetando
  • Foto
  • Laboratorio
  • Empleado
  • Muestra
  • Examinar
  • Encima
  • Europeo
  • Pose
  • Mutaciones
  • Identificar
  • Plazo
  • Secuenciación
  • Coronavirus
  • Llamada
  • Heidelberg
  • Severidad
  • Uwe
  • Particular
  • Merkel
  • Embl
  • Efficaciousness
  • Sistemáticamente
  • Anspach
  • Biología Molecular
  • Secuenciador De Adn
  • Baden-Württemberg
  • Dpa
  • Transmisibilidad
  • 2019-Ncov
  • Coronavirus De Wuhan
  • Covid-19
  • Sars-Cov-2
  • Armin Laschet